EXOZ - NASDAQ

eXoZymes, Inc.

EXOZ·NASDAQ

$9.46

-2.2%

HealthcareBiotechnology

eXoZymes, Inc. operates as a synthetic biochemical company in the United States. The company develops SimplePath, a platform that produces chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. Its platform also comprises one or more module which consist of one or more enzymes that work together to perform a defined biocatalytic conversion. The company was founded in 2014 and is headquartered in Monrovia, California.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$80.21M

EPS-1.0900

P/E Ratio-8.68

Earnings Date05/14/2026

exoz

Operating Expenses

Last Annual Value

9.72M

3-Year CAGR

102%

5-Year CAGR

51%

10-Year CAGR

23%

Adjust for Inflation

eXoZymes, Inc. Competitors Analysis of Operating Expenses

EXOZ · NASDAQ

Company	Operating Expenses	CAGR 3Y	CAGR 5Y	CAGR 10Y
eXoZymes, Inc. NASDAQ:EXOZ	9.72M	75.5%	51.1%	N/A
aTyr Pharma, Inc. NASDAQ:ATYR	76.26M	11.3%	18.4%	2.7%
MacroGenics, Inc. NASDAQ:MGNX	179.16M	-6.2%	-8.3%	2.0%
Metagenomi, Inc. Common Stock NASDAQ:MGX	115.91M	59.0%	37.2%	N/A
Zentalis Pharmaceuticals, Inc. NASDAQ:ZNTL	145.01M	-21.5%	-7.7%	N/A
Quince Therapeutics, Inc. NASDAQ:QNCX	57.28M	18.3%	-8.7%	N/A
Atossa Therapeutics, Inc. NASDAQ:ATOS	37.14M	5.8%	12.6%	17.7%
Anebulo Pharmaceuticals, Inc. NASDAQ:ANEB	9.22M	-7.8%	20.6%	N/A
Instil Bio, Inc. NASDAQ:TIL	52.37M	-31.0%	-19.6%	N/A
Greenwich LifeSciences, Inc. NASDAQ:GLSI	19.45M	27.7%	33.4%	N/A
Tevogen Bio Holdings Inc. NASDAQ:TVGN	53.16M	84.5%	63.0%	N/A

eXoZymes, Inc. Fair Value Envelope

EXOZ · NASDAQ

Our analysis suggests that EXOZ has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $9.46, this represents a potential HIDDEN relative to our calculated worth for eXoZymes, Inc..

HIDDEN

Intrinsic Value

Current Price: $9.46

Related Guides

Blog Categories

Continue your EXOZ research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.